Better Coronavirus Stock: Eli Lilly or AbbVie?
Both of these stocks have strong growth potential.
Is Walgreens Stock a Buy?
There are a few things to consider before scooping up Walgreens shares.
2 Top Diabetes Stocks to Buy Right Now
These are two worthy contenders for your investment portfolio.
Could Bristol Myers Squibb Be a Millionaire-Maker Stock?
This healthcare stock could be a gamechanger for long-term investors who buy in today.
Better Buy: Novartis vs. Teva Pharmaceutical
It's a face-off between an incredibly cheap stock and a pharmaceutical giant.
Is Eli Lilly Stock a Buy?
There are more than a few reasons to like this tried-and-true stock.
Is Amgen Stock a Buy?
Should you scoop up this large-cap stock?
Why Is Everyone Talking About Gilead Sciences Stock?
This stock has dominated the headlines of late.
The Top 5 Mental Health Startups of 2020
These five mental health startups offer apps and online services for one-on-one counseling, meditation, mindfulness, and more.
Should Teladoc Be Worried About Zocdoc's New Telehealth Service?
Zocdoc has serious disruptor potential.
Better Buy: Bristol Myers Squibb vs. Gilead Sciences
Which of these household names is the better buy?
Health and Wellness Startup Everlywell Selling At-Home Coronavirus Test Kits for $109
With this self-administered nasal swab test, you can have a confirmed COVID-19 diagnosis in two days or less.
Moderna Shares Up Almost 250% This Year as Vaccine Trials Continue
This stock is making big moves on the heels of positive interim data from phase 1 human trials of Moderna's COVID-19 vaccine candidate.
Better Buy: GlaxoSmithKline vs. Pfizer
Both companies are weathering the bear market well as they lead the race to develop the coronavirus vaccine. But which is the better buy?
23andMe Is Trying to Crack the Genetic Code Behind the Coronavirus
The genomics and biotechnology company has launched a comprehensive genetic study in an effort to discover why COVID-19 elicits such an acute response in some patients but not in others.
As COVID-19 Rocks Markets, Digital Health Start-Ups Rake In Cash
These three healthcare start-ups have serious disruptor potential.
Is Rite Aid Stock a Buy?
Here's why you may want to think twice before scooping up shares.
Here's Why Investors Should Follow Sanofi and GlaxoSmithKline's New Coronavirus Collaboration
The combined effort of these two companies marks one of the largest manufacturing collaborations on the planet toward a coronavirus vaccine.
3 Dividend Stocks Weathering the Coronavirus Storm
These three stocks aren't just surviving the coronavirus storm -- they're thriving in it.
Pfizer Gets German Approval To Start COVID-19 Vaccine Human Trials; Potential Treatment Also In The Works.
Pfizer is developing a potential coronavirus treatment and a vaccine candidate. With potential big wins in the near future, is now the time to buy?